We present here the first report of a cohort of 30 CVID patients treated with immunoglobulin substitution therapy and 59 CLL nonsubstituted patients with confirmed decrease in anti-Gal IgA and IgM. Here, GAL is linked to B-cell chronic lymphocytic leukemia.